<DOC>
	<DOCNO>NCT01471093</DOCNO>
	<brief_summary>The purpose study assess safety OPC-12759 ophthalmic solution healthy subject .</brief_summary>
	<brief_title>Safety Study OPC-12759 Ophthalmic Solution</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>BMI : { body weight ( kg ) / [ height ( ) ] 2 } must 17.6 great , less 26.4 kg/m2 1 . Presence ocular disorder 2 . Intraocular pressure 21mmHg high 3 . Corrected visual acuity le 1.0 4 . Dysfunction nasolacrimal duct history surgery relate nasolacrimal duct eye lid affect nasolacrimal outflow 5 . History refractive surgery 6 . History ocular surgery within 12 month 7 . Those discontinue use contact lenses 1st dose 5hourpostdose</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>